Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Wuhan, Hubei, 430022, China
NCT Number: NCT07829640
This investigator-initiated, single-center study consists of a retrospective artificial intelligence model-development stage and a prospective physician reader-study stage. Deidentified chest CT examinations acquired during routine clinical care between January 1, 2021, and December 31, 2024, will be used to develop, validate, and lock artificial intelligence models for lung cancer-related imaging tasks.
In the prospective stage, approximately 12 to 15 physicians with experience in chest CT interpretation will complete two reading sessions in randomized order: unaided interpretation and AI-assisted interpretation. The sessions will be separated by a washout period of at least 4 weeks. The primary objective is to compare diagnostic performance between AI-assisted and unaided interpretation. Secondary objectives include reading time, diagnostic confidence, inter-reader agreement, and errors related to incorrect AI suggestions.
All readings will be performed in an offline research environment. AI outputs will not be used for patient care, and the study will not add imaging examinations, treatment, or follow-up for patients.
Trial opening soon.
Get Notified18 year and older
All sexes
Interventional
Not applicable
Wuhan, Hubei, 430022, China
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
A locked research-use-only artificial intelligence system analyzes deidentified chest CT images and provides decision-support outputs to participating physicians. The system is evaluated only in an offline reader-study environment and is not used for actual patient care.
Time frame: At completion of the second reading session, after a washout period of at least 4 weeks
Diagnostic accuracy will be calculated as the proportion of case-level interpretations that agree with the prespecified reference standard based on pathology or clinical follow-up. The paired difference in diagnostic accuracy between AI-assisted and unaided interpretation will be estimated across participating physicians and cases using a multi-reader multi-case analysis and reported with a 95% confidence interval. Higher accuracy indicates better diagnostic performance.
Contact information is provided by the study sponsor or research team.
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Other
Development of a Chest CT-Based Artificial Intelligence Model Across the Lung Cancer Care Continuum and a Prospective Randomized Crossover Reader Study of Its Clinical Decision-Support Performance
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07830095
Lung Cancer, Lung Diseases
Shanghai, China
View Trial DetailsNCT07824544
Disease, Lung Cancer
Vejle, Denmark
View Trial DetailsNCT07279948
Lung Cancer, Lung Diseases
Rio de Janeiro, Brazil
View Trial DetailsNCT07104253
Lung Cancer, Lung Diseases
View Trial Details